Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 4
This trial looked at gefitinib as the first treatment for advanced non small cell lung cancer (NSCLC).
Recruitment start: 8 September 2010
Recruitment end: 15 February 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ferry
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 17 Feb 2015
CRUK internal database number: 7415